Cellebrite kündigt bevorstehende Investorenveranstaltungen am 10. Juni 2026 an
05-06-2026 18:51 via prnewswire.com

Cellebrite kündigt bevorstehende Investorenveranstaltungen am 10. Juni 2026 an

TYSONS CORNER, Va. und PETAH TIKVA, Israel, 5. Juni 2026 /PRNewswire/ -- Cellebrite DI Ltd. (NASDAQ: CLBT), ein weltweit führender Anbieter von KI-gestützten Lösungen für digitale Ermittlungen und Informationsgewinnung im öffentlichen und privaten Sektor, gab heute bekannt, dass das...
Read more »

PR Public relations news



LOS SIETE DISTRITOS CULTURALES DE HOUSTON LANZAN HTXARTS: UNA GUÍA GRATUITA PARA LA ESCENA ARTÍSTICA DE LA CIUDAD ESTE VERANO
Think Together Awards 2026 Beyond Think Together Scholarships to Ten High School Seniors Across the State
Think Together Awards 2026 Beyond Think Together Scholarships to Ten High School Seniors Across the State
Ractigen Therapeutics Announces ADA 2026 Late-Breaking Presentation Highlighting saRNA as a New Frontier in Obesity Control
46 Greenberg Traurig Attorneys Recognized in 2026 IAM Patent 1000
46 Greenberg Traurig Attorneys Recognized in 2026 IAM Patent 1000
Millionen Besitzer von Elektrofahrzeugen werden durch die vertrauenswürdigste Batteriekennzahl der Branche in die Irre geführt!
Millionen Besitzer von Elektrofahrzeugen werden durch die vertrauenswürdigste Batteriekennzahl der Branche in die Irre geführt!
Tishman Speyer sichert sich 300 Millionen US-Dollar beim First Closing für Korea Living Venture mit APG und Bouwinvest
Tishman Speyer sichert sich 300 Millionen US-Dollar beim First Closing für Korea Living Venture mit APG und Bouwinvest
Ambrosia Biosciences Announces Preclinical Data Supporting Differentiated Profile of AMB-702, its Novel Small Molecule GLP-1 Receptor Agonist Development Candidate
Novo Nordisk's investigational zenagamtide shows significant A1C reductions with up to 14.6% weight loss in adults with type 2 diabetes--presented at ADA 2026
Novo Nordisk's investigational zenagamtide shows significant A1C reductions with up to 14.6% weight loss in adults with type 2 diabetes--presented at ADA 2026
Machine Learning Model Accurately Predicts Long-Term Risk of Type 2 Diabetes
Machine Learning Model Accurately Predicts Long-Term Risk of Type 2 Diabetes
Bio Preventive Medicine and Precision Diabetes Announce ADA Late-Breaking Presentation Highlighting DNlite™ in Landmark CREDENCE Trial
Bio Preventive Medicine and Precision Diabetes Announce ADA Late-Breaking Presentation Highlighting DNlite™ in Landmark CREDENCE Trial
Marvell Technology and Flex Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
The City of Hallandale Beach Among 10 Finalists for Climate Protection from US Conference of Mayors; Cloud Receives Small City Award
/C O R R E C T I O N -- Pugsley Wood LLP/
/C O R R E C T I O N -- Pugsley Wood LLP/
Xsolis, Inc. Provides Notice of Data Security Incident
Desktop versie